News
Aimed at addressing systemic inflammation, National Rosacea Society treatment algorithms take a phenotype-driven approach ...
Hosted on MSN2mon
Oppenheimer lifts Tarsus stock target, impressed by execution and ocular rosacea potentialThe commentary focused on Tarsus Pharmaceuticals' impressive sales figures for their product XDEMVY, particularly highlighting its potential in treating ocular rosacea. The company has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results